PTGX
PTGX
NASDAQ · Biotechnology

Protagonist Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$100.39
+1.85 (+1.88%)
As of Mar 24, 9:53 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 17 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -69.6% upside
Low Target $24.78
Average Target $30.47
High Target $49.57
Current Price $100.39
Current
$100.39
Target
$30.47
$24.78 $30.47 avg $49.57
Scenario Analysis
Bear Case
$24.78
-75.3%
Low target
Base Case
$30.47
-69.6%
Avg target
Bull Case
$49.57
+-50.6%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$105.69
-5.0% from high
52-Week Low
$39.60
+153.5% from low
50-Day SMA
$85.10
+18.0% vs SMA
200-Day SMA
$67.75
+48.2% vs SMA
RSI (14)
58.3
Neutral
Target vs 52W High
$30.47
-71.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%